Profil
Sarah Ankri is currently the Director at France Biotech Association since 2014.
Prior to this, she worked as the Chief Financial Officer at Théraclion SA from 2013 to 2014 and as the Vice President-Finance at Lysogene SA. She also worked as a Manager-Financial Audit at Ernst & Young Audit SAS (France).
Ms. Ankri completed her undergraduate degree from Institut National Agronomique Paris-Grignon.
Aktive Positionen von Sarah Ankri
| Unternehmen | Position | Beginn |
|---|---|---|
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services Operates an organisation for growth of health industry | Direktor/Vorstandsmitglied | 12.06.2014 |
Ehemalige bekannte Positionen von Sarah Ankri
| Unternehmen | Position | Ende |
|---|---|---|
Ernst & Young Audit SAS (France)
Ernst & Young Audit SAS (France) Miscellaneous Commercial ServicesCommercial Services Provides Auditing & Accounting Services | Comptroller/Controller/Auditor | - |
| LYSOGENE | Finanzdirektor/CFO | - |
| THERACLION | Finanzdirektor/CFO | - |
Ausbildung von Sarah Ankri
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Institut National Agronomique Paris-Grignon
Institut National Agronomique Paris-Grignon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernst & Young Audit SAS (France)
Ernst & Young Audit SAS (France) Miscellaneous Commercial ServicesCommercial Services Provides Auditing & Accounting Services | Commercial Services |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services Operates an organisation for growth of health industry | Commercial Services |
Théraclion SA
Théraclion SA Medical SpecialtiesHealth Technology Manufactures and markets utlra sound medical products | Health Technology |
Lysogene SA
Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
















